Tdap Vaccine During Pregnancy Seems Safe for Mother, Infant

Share this content:
Tdap Vaccine During Pregnancy Seems Safe for Mother, Infant
Tdap Vaccine During Pregnancy Seems Safe for Mother, Infant

TUESDAY, Nov. 1, 2016 (HealthDay News) -- The tetanus, diphtheria, and pertussis (Tdap) vaccine does not appear to cause birth defects or any other major health problems for a developing fetus, according to a research letter published in the Nov. 1 issue of the Journal of the American Medical Association.

Malini DeSilva, M.D., M.P.H., a clinical investigator for the HealthPartners Institute in Minneapolis, and colleagues included data from 324,463 live births between 2007 and 2013 at seven Vaccine Safety Datalink sites, including northern California, southern California, Colorado, Minnesota, Oregon, Washington, and Wisconsin. The investigators analyzed births from these areas when Tdap vaccination became recommended for pregnant women, and compared the results to what occurred prior to the recommendation.

The researchers found that maternal Tdap inoculation wasn't significantly associated with increased risk for any major birth defects in vaccinations occurring at less than 14 weeks' gestation, between 27 and 36 weeks' gestation, or during any week of pregnancy.

"We basically showed there is no association between receiving the Tdap vaccine during pregnancy and these congenital defects, including microcephaly," DeSilva told HealthDay. The study is part of ongoing efforts to monitor the safety of vaccines, DeSilva said. Her center is part of the Vaccine Safety Datalink, a collaborative project led by the U.S. Centers for Disease Control and Prevention that includes health care organizations across the nation.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

ASCO: Moderate Activity Tied to Longer Survival in Advanced CRC

ASCO: Moderate Activity Tied to Longer Survival in ...

Patients only appeared to derive benefit from moderate -- not vigorous -- activity

Number of Infants Born to Women Using Opioids Up Sharply

Number of Infants Born to Women Using Opioids ...

Few treatment programs deal with substance abuse in expectant moms, federal report says

Hypertension Onset After Age 80 May Protect Against Dementia

Hypertension Onset After Age 80 May Protect Against ...

Association independent of antihypertensive medication use

is free, fast, and customized just for you!

Already a member?

Sign In Now »